InMode
InMode

InMode

Health Care Equipment & Supplies
WebsiteInvestor RelationsSEC
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.

$844.6M

Market Cap • 11/6/2026

2008

(18 years)

Founded

2019

(7 years ago)

IPO

NASDAQ

Listing Exchange

Flag of Israel

Israel

Country

Valuation

P/B

—

P/S

2,3

P/EBITDA

12,1

P/OCF

10,1

P/FCF

10,2

P/E

10,8

BVPS

—

EPS

1,2

Market Cap

Market Cap

844,6M

EV

347,9M

EV/Revenue

0,9

EV/EBITDA

5

EV/EBIT

5

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

10,5%

Total Yield

10,5%

Payout

0%

Profitability

Gross Margin

76,5%

EBITDA Margin

18,7%

EBIT Margin

18,5%

Net Margin

20,7%

D&A/EBITDA

0%

R&D/Revenue

3,8%

Capex/Revenue

0,3%

Capex/D&A

153,7%

Capex/OCF

1,3%

SBC/OCF

13,9%

% PPE

1,6%

% Goodwill

0%

ROE

12,3%

ROIC

51,1%

Growth

CAGR Revenue 5Y

5,4%

CAGR Op. Income 5Y

-11,4%

CAGR Net Income 5Y

-9,5%

CAGR EPS 5Y

-3,9%

CAGR OCF 5Y

-10,2%

Leverage

N.D./EBITDA

—

Debt/Equity

0%

Current Ratio

8,2

Quick Ratio

6,9

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium